Search results
Results from the WOW.Com Content Network
The US Food and Drug Administration has approved the company Guardant Health’s Shield blood test for colorectal cancer screening in adults, 45 and older, who are at average risk for the...
The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating ...
Palo Alto, California-based biotechnology company Guardant Health has applied for US Food and Drug Administration approval of Shield, its blood test to screen for early signs of colorectal...
On July 29, 2024, the Food and Drug Administration (FDA) approved a blood test that can help with primary colorectal cancer screening. The test is Guardant Health’s Shield blood test,...
In July, the Food and Drug Administration (FDA) approved the first blood test to use as primary screening for people at average risk for colon cancer. Called Shield, the test looks for the presence of specific changes to DNA floating freely in the blood, called cell-free DNA, that indicate the presence of a tumor or precancerous growths in the ...
An FDA independent advisory panel recommended that a blood test to detect colon cancer be approved. Here's what you need to know.
In 2024, the FDA approved a blood test called Shield as a screening method for colorectal cancer. The test detects 83% of colorectal cancers, but only 13% of precancerous polyps. The FDA approval means that now many insurance plans will pay for the test.
The device is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA (cfDNA) from plasma isolated from the whole blood collected in...
The Food and Drug Administration on Monday approved a new screening test for colorectal cancer. It requires only a sample of blood and can find cancers when they are early stage and...
With the approval of the Shield screening, patients can have their blood drawn as a diagnostic test option to screen for colorectal cancer. Shield can detect the DNA particles in the bloodstream emitted by cancer cells and large polyps, which are cell clusters on the colon that can become cancerous, thereby detecting the presence of cancer ...